Athanor Capital, LP Adaptive Biotechnologies Corp Transaction History

Athanor Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $213,723 - $388,556	-5,736 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $258,177 - $375,535	5,736 New	5,736 $339,000
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $558,288 - $761,387	-15,599 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $389,195 - $754,679	15,599 New	15,599 $755,000
Q1 2020 May 14, 2020	SELL	$16.96 - $34.16 $345,984 - $696,863	-20,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $61,400 - $82,000	-2,500 Reduced 10.92%	20,400 $610,000
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $694,099 - $1.23 Million	22,900 New	22,900 $708,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.